Novel breakthroughs in advanced prostate cancer management.

Lilly, Eddy; Sarkis, Julien; Mahmoud, Omar; El Gharib, Khalil; Sarkis, Pierre; Nemr, Elie

Lilly, Eddy; Sarkis, Julien; Mahmoud, Omar; El Gharib, Khalil; Sarkis, Pierre; Nemr, Elie.

Afiliação

Lilly E; Urology Department, Faculty of Medicine, Saint-Joseph University, Beirut, Lebanon.
Sarkis J; Urology Department, Faculty of Medicine, Saint-Joseph University, Beirut, Lebanon.
Mahmoud O; Hematology-Oncology Department, Faculty of Medicine, Saint-Joseph University, Beirut, Lebanon.
El Gharib K; Department of Medicine, STATEN Island University Hospital, New York, NY, USA.
Sarkis P; Department of Urology, Saint Joseph Hospital, Beirut, Lebanon.
Nemr E; Urology Department, Faculty of Medicine, Saint-Joseph University, Beirut, Lebanon.

Expert Rev Anticancer Ther ; 23(4): 369-373, 2023 04.

Article em En | MEDLINE | ID: mdl-36951118

Assuntos

Neoplasias de Próstata Resistentes à Castração; Neoplasias da Próstata; Masculino; Humanos; Neoplasias da Próstata/patologia; Neoplasias de Próstata Resistentes à Castração/patologia; Antagonistas de Androgênios/farmacologia; Antagonistas de Androgênios/uso terapêutico; Inibidores de Poli(ADP-Ribose) Polimerases/farmacologia; Inibidores de Poli(ADP-Ribose) Polimerases/uso terapêutico

Palavras-chave

Biomarkers; Immunotherapy; Nivolumab; Olaparib; PARP inhibitors; Prostate cancer; Rucaparib; Targeted radionuclide therapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Neoplasias de Próstata Resistentes à Castração Limite: Humans / Male Idioma: En Revista: Expert Rev Anticancer Ther Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google